Antimicrobial Agents Flashcards
antibiotic
chemical produced by one microbe and has the ability to harm other microbes
antimicrobial drug
any agent, natural or synthetic, that has the ability to kill or suppress microorganisms
bacteriocidal
directly lethal to bacteria at clinically achievable concentrations
bacteriostatic drugs
slow bacterial growth but do not cause cell death
Selective toxicity
ability of a drug to injure a target cell or target organism without injuring other cells or organisms that are in the intimate contact with the target
narrow-spectrum antibiotics
active against only a few species of microorganisms
broad-spectrum antibiotics
active against a wide variety of microbes
Four basic mechanisms for drug resistance from microbes
- decrease concentration of a drug at its site location.
- alter the structure of drug target molecules.
- produce a drug antagonist.
- cause drug inactivation.
causes random changes in a microbe’s DNA
spontaneous mutations
process by which extrachromosomal DNA is transferred from one bacterium to another.
conjugation
R factor (resistance factor)
- code for mechanism of drug resistance.
- cod for sexual apparatus for DNA transfer.
Conjugation takes place in primarily what bacteria?
Gram-negative
multiple drug resistance
transferring DNA that codes for several different drug-metabolizing enzymes to a single bacterium
which antibiotic agents promore the emergence of resistance
broad-spectrum agents
Superinfection
new infection that appears during the course of treatment for a primary infection, ridding inhibitory nature of normal flora, allowing infectious agent to flourish
superinfections are more likely in which type of patients
those receiving broad-spectrum agents
therapeutic objective when treating an infection
produce maximal antimicrobial effects, while causing minimal harm to the host
factors considered when prescribing a new antibiotic
- identity of the infecting organism.
- drug sensitivity of the infecting organism.
- host factors, site of the infection and the status of host defenses.
why will one drug of first choice be chosen over another one
greater efficacy, lower toxicity, more narrow spectrum
conditions ruling out first choice drug of choice
- allergies to drug.
- inability of drug of choice to penetrate to the side of infection.
- heightened susceptibility of the patient to toxicity of the first-choice drug.
two host factors that influence the selection of antibiotics
host defense and infection site.
Also: age, pregnancy, previous drug reactions.
host defenses
primarily of the immune system and phagocytic cells - antimicrobial therapy would be rare without it (concert).
minimum inhibitory concentration (MIC)
amount of bacteriocide at the site of infection
Antimicrobial concerns in infants
vulnerable to drug toxicity. Eliminate drugs slowly. No sulfonamides, kernicterus.
Antimicrobial concerns in children/adolescents
tetracyclines bind to developing teeth, causing discoloration.A
Antimicrobial concerns in pregnant women.
Placental crossing. Gentamicin, irreversible hearing loss. Also risk to mother
Antimicrobial concerns in breastfeeding women
enter breast milk. Sulfas cause kernicterus in infants
Antimicrobial concerns in older adults
reduced metabolism and excretion can result in accumulation
desirable concentrations for antibiotics
4-8x the MIC
Antimicrobial effect of 2 drugs is equal to the sum f the effects of the two drugs alone
additive response
the effect of the combination is grater than the sum of the effects of the individual agents
potentiative interaction
less effective therapy with 2 drugs than the use of one by itself
antagonism
most common indication for using multiple antibiotics
initial therapy for severe infection of unknown etiology, especially in the neutropenic host.
indications for antibiotic combinations
- initial therapy of severe infection.
- mixed infections.
- preventing resistance.
- decreased toxicity.
- enhanced antibacterial action.
locations susceptible to mixed infections
brain abscesses, pelvic infections, abd perf organs
infectious disease treated by multiple antibiotic combination
tuberculosis
combining amphotericin B with flucytosine does what
decreases toxicity - decreases risk of amphotericin-induced damage to kidneys
antibiotic treatment for enterococcal endocarditis
penicillin (weakens wall) and aminoglycoside (supress protein synthesis) - enhanced bacterial action
percentage of antibiotics used for prophylaxis
30-50%
surgical cases considered 100% infection risk, for which antibiotics is a treatment
contaminated surgery - perforated abdominal organs, compound fractures, lacerations from animal bites
most operations antibiotic choice
first-generation cephalosporin
bacterial endocarditis
congenital or valvular heart disease with prosthetic heart valves - unusually susceptible. Dislodge bacteria into bloodstream. AHA - much less often than previously prescribed.
much smaller number of neutrophils, which indicates for prophylactic antibiotic use
neutropenia
neutropenia prophylactic antibiotic use increases risk for
fungal infections - killing normal flora that suppresses fungal growth
prophylaxis for recurrent UTI
trimethoprim/sulfamethoxazole
prophylaxis against influenza
oseltamivir
bactericidal that disrupt the bacterial cell wall
beta-lactam
rigid, permeable, mesh-like structure that lies outside the cytoplasmic membrane
bacterial cell wall
penicillin mechanism of action
weakens bacterial cell wall, cell takes up water and bursts
penicillin is only effective against bacteria
undergoing growth and division
how does penicillin weaken the cell wall
- inhibition of transpeptidases
- disinhibition (activation) of autolysins
factors to determine bacterial resistance to penicillins
- inability of penicillins to reach their targets (PBPs)
beta-lactamases
enzymes that cleave the beta-lactam ring rendering beta-lactam antibiotics inactive
beta-lactamases that act selectively on penicillins
penicillinases
produce large amounts of penicillinases and export them into the surrounding medium
gram-positive bacteria
produce small amounts of penicillinases and secrete them into the periplasmic space
gram-negative bacteria